Activity of vancomycin, ciprofloxacin, daptomycin and linezolid against coagulase-negative staphylococci bacteremia;Actividad de vancomicina, ciprofloxacino, daptomicina y linezolid frente Staphylococcus coagulasa negativo aislados en hemocultivos

Revista Espanola de Quimioterapia

Volumn 24, Issue 2, 2011, Pages 74-78

  Olivares, Miguel Fajardo ^a   Orozco, Rocío Hidalgo ^a   Garrido, Saray Rodríguez ^a   Rodríguez Vidigal, Francisco Félix ^a   Tomé, Araceli Vera ^a   Marcos, Manuel Robles ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Antimicrobial resistance; Blood culture; Coagulase Negative Staphylococci

Indexed keywords

CIPROFLOXACIN; DAPTOMYCIN; LINEZOLID; VANCOMYCIN; ACETAMIDE DERIVATIVE; OXAZOLIDINONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG ACTIVITY; HUMAN; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; BACTEREMIA; CATHETER INFECTION; CROSS INFECTION; DRUG EFFECT; HOSPITAL DEPARTMENT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PENICILLIN RESISTANCE; SPAIN; STAPHYLOCOCCUS INFECTION; STATISTICS; UNIVERSITY HOSPITAL;

ACETAMIDES; BACTEREMIA; CATHETER-RELATED INFECTIONS; CIPROFLOXACIN; CROSS INFECTION; DAPTOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITAL DEPARTMENTS; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; SPAIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; VANCOMYCIN;

EID: 80054777736     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in U.S. hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-17.
2. John MA, Pletcher C, Hussain Z. In vitro activity of quinupristin / dalfopristin, linezolid, telithromycin and comparator antimicrobial agents against 13 species of coagulase-negative staphylococci. J Antimicrob Chemother 2002; 50:933-8.
3. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004, 42:2398-402.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth Informational Supplement. M100-S18. Wayne: Clinical and Laboratory Standards Institute, 2008.
5. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approbed Standard. M7-A7. 7 th ed. Wayne: Clinical and Laboratory Standards Institute, 2006.
6. Darley E, NcGrowan A. Antibiotic treatment of Gram-positive bone and joint infection. J Antimicrob Chemother 2004; 53:928-35.
7. Cuevas O, Rump E, Goyanes MJ, Vindel A, Trincado P, Boquete T. Staphylococci in Spain: current status and evolution of antimicrobial resistance (1986-2006). Enferm Infecc Microbiol Clin 2008, 26:269-77.
8. Kuti JL, Kiffer CRV, Mendes CMF, Nicolau DP. Pharmacodinamyc Comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negativestaphylococci collected from hospitals in Brazil. Clin Microbiol Infect 2008, 14:116-23.
9. Drozenova J, Petras P. Characterictics of coagulase negative staphylococci isolated from hemocultures. Epidemiol Mikrobiol Imunol 2000; 49:51-8.
10. Huang SY, Tang RN, Chen SY. Coagulase negative staphylococcal bacteremia in critically ill children: risk factors and antimicrobial susceptibility. J Microbiol Immunol Infect 2003; 36:51-5.
11. Knauer A, Fladerer P Strempfl C. Effect of hospitalization and antimicrobial therapy on antimicrobial resistance of colonizing Staphylococcus epidermidis. Wien Klin Wochenschr 2004, 116:489-94.
12. Hamilton JMT, Shah S. Activities of ciprofloxacin, levofloxacin, ofloxacin and sparfloxacin against speciated coagulase-negative staphylococci sensitive and resistant to fluoroquinolones. Int J Antimicrob Agents 1997; 9:127-30.
13. Mangili A, Bica I, Snydman DR. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2005; 40:1058-60.
14. Mensa J, Barberan J, Llinares P, Picazo JJ, Bouza E, Alvarez Lerma F, et al. Guide treatment of infections caused by methicillin-resistant Staphylococcus aureus. Rev Esp Quimioter 2008, 21:234-58.
15. Ponticelli C. New recommendations in the treatment of Greatpositive bacteraemia in dialysis patients. Nephrol Dial Transplant 2008, 23:27-32.
16. Fuchs PC, Barry AL, Brown SD. In vitro antibacterial activity of daptomycin against staphylococci. J Antimicrob Chemother 2002; 49:467-70.
17. Silverman JA, Pelmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:2538-44.
18. Ross JE, Anderegg TR, Sader HS, Fritsche TR, Jones RN. Trends in linezolid susceptibility Pattensen in 2002: report from worldwide Zyvox Annual Appraisal of Potency and Spectrum Program. Diagn Microbiol Infect Dis 2005; 52:53-8.
19. Potoski BA, Adams J, Clarke L. Epidemiological profile of linezolid-resistant coagulase-negative staphylococci. Clin Infect Dis 2006; 43:165-71.
20. John JF, Harvin AM. History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents. Therap Clin Risk Managem 2007, 3:1143-52.